AFP and cancer: There are numerous classical cancer markers used clinically, such as alpha fetoprotein (AFP) and carcinoembryonic antigen (CEA), meanwhile, increasing numbers of new cancer markers are being discovered, such as vascular endothelial growth factors (VEGF) [11].